Grignon, David J.

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

Shipley, W. U., Seiferheld, W., Lukka, H. R., Major, P. P., Heney, N. M., Grignon, D. J., Sartor, O., Patel, M. P., Bahary, J.-P., Zietman, A. L., et al. (2017) · New England Journal of Medicine

Prostate Cancer Diagnosis and TreatmentProstate Cancer Treatment and Research

Cited by 663

Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study

Ström, P., Kartasalo, K., Olsson, H., Solorzano, L., Delahunt, B., Berney, D. M., Bostwick, D. G., Evans, A. J., Grignon, D. J., Humphrey, P. A., et al. (2020) · The Lancet Oncology

AI in cancer detectionArtificial Intelligence in Healthcare and Education

Cited by 620

MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02

Khor, L.-Y., Bae, K., Paulus, R., Al-Saleem, T., Hammond, M. E., Grignon, D. J., Che, M., Venkatesan, V., Byhardt, R. W., Rotman, M., et al. (2009) · Journal of Clinical Oncology

Prostate Cancer Diagnosis and TreatmentProstate Cancer Treatment and Research

Cited by 102